8-K

Company

Compass Therapeutics, Inc.

Filed

September 15, 2020

Period of Report

September 10, 2020

Accession Number

0001193125-20-245916

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →